Cite

HARVARD Citation

    Miyakawa, M. et al. (n.d.). P-059 Short-Term Outcomes of Adalimumab for Japanese Patients with Crohn's Disease and Associated Prognostic Factors. Inflammatory bowel diseases. p. . [Online]. 
  
Back to record